Dr. Daniel P. Petrylak discusses the different types of bladder cancer and how treatment options may vary based on disease ...

Dr. Daniel P. Petrylak sits down with CURE during Bladder Cancer Awareness Month to discuss key topics for patients with the ...

Bill Russell and Jim Rieker are survivors. Both diagnosed with bladder cancer, the men have made it their mission to help ...

A study published in ACS Nano presents a novel biosensor for the isothermal, highly sensitive detection of bladder cancer ...

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...

Roughly 85,000 people in the U.S. will be diagnosed with this common cancer this year alone. Newsom Wants to End Free Health ...

AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in non-muscle invasive bladder cancer (NMIBC). Top-line results from ...

Some deubiquitinating enzymes may help protect against cancer, but others appear to promote it. Researchers from the First Affiliated Hospital of Zhejiang University have discovered that the ...

The first targeted drug for a common form of bladder cancer that can be taken at home has been backed for NHS use, offering hope of simpler treatment to hundreds of patients in England.